SCHEMBL30714569

SCHEMBL30714569

Cn1nc2ccc(OCc3cccnc3C(F)(F)F)cc2c1C(=O)NC1(C(=O)O)CCOC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
OPRL1 P41146 2/20 0.34
ADAM17 P78536 3/20 0.34
MMP3 P08254 2/20 0.34
MMP7 P09237 2/20 0.34
CXCR2 P25025 1/20 0.34
ADAMTS4 O75173 1/20 0.34
ADAMTS1 Q9UHI8 1/20 0.34
ADAMTS5 Q9UNA0 1/20 0.34
MMP13 P45452 2/20 0.33
MMP2 P08253 1/20 0.33
MMP12 P39900 1/20 0.33
GPR132 Q9UNW8 3/20 0.33
MAPT P10636 3/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26696044 1.00 CYP4F2 (0.34) CYP4F2CYP4A11OPRL1ADAM17MMP3
SCHEMBL30714572 0.93 ANO1 (0.33) CYP4F2CYP4A11OPRL1ADAM17MMP3
SCHEMBL26696014 0.93 ANO1 (0.33) CYP4F2CYP4A11OPRL1ADAM17MMP3
SCHEMBL30714574 0.93 CD38 (0.33) CYP4F2CYP4A11OPRL1ADAM17MMP3
SCHEMBL26875162 0.93 GRM2 (0.33) OPRL1ADAM17MMP3MMP7CXCR2
SCHEMBL30714552 0.92 ADAM17 (0.31) OPRL1ADAM17MMP3MMP7CXCR2
SCHEMBL30714673 0.89 CD38 (0.35) OPRL1ADAM17MMP3MAPTL3MBTL1
SCHEMBL30714699 0.87 ADAM17 (0.39) ADAM17MMP3MMP7ADAMTS4ADAMTS1
SCHEMBL30714680 0.84 SCN9A (0.38) OPRL1ADAM17MMP13CACNA1GCACNA1H
SCHEMBL30714603 0.83 ADAM17 (0.34) OPRL1ADAM17MMP13CACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499624-A2 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-02-05 EP disclosed
WO-2023230540-A2 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed